Specialized Center of Research Program
Interdisciplinary research, collaboration and teamwork in the effort to cure and better treat blood cancers is what's behind The Leukemia & Lymphoma Society's (LLS's) Specialized Center of Research Program.
The Marshall A. Lichtman Specialized Center of Research (SCOR) program is our most ambitious research opportunity to date. This innovative program supports interdisciplinary research across at least three independent research projects that are integrated and supported by scientific core laboratories.
Members of our SCOR teams include some of the brightest medical specialists in the field of leukemia, lymphoma and myeloma research--brought together to be part of a highly organized and inspired team approach to speed the discovery of new drugs and curative treatment.
We invite you to be part of an innovative, interdisciplinary research team and a catalyst in helping to develop groundbreaking treatment for leukemia, lymphoma and myeloma.
NOTE: We are not soliciting applications during this award cycle. An announcement will be made regarding re-opening the program for fiscal year 2015.
Not to exceed $1.25 million, which includes direct and indirect costs. Aggregate costs over five years cannot exceed $6.25 million. Direct costs, if justified by the aggregate budget, may be up to $1.042 million per year. The indirect or institutional costs cannot exceed 20 percent of the direct costs per year.
SCOR grantees may apply for additional funding after five years depending on progress shown. These applications for additional funding will compete with all applications received by LLS for that academic year. NOTE: We will not be accepting renewal applications during fiscal year 2014.
Need More Information?
Director of Research Administration
The Leukemia & Lymphoma Society
1311 Mamaroneck Ave.
White Plains, NY 10605